Karen Hartwell, M.D.
Clinical Neuroscience Division (CND)
(843) 792-3982 fax
My research career has focused on understanding the underlying neurobiology and improving treatment outcomes of addictive disorders with an emphasis on nicotine dependence. I have extensive clinical experience as a general and addiction psychiatrist in the treatment of substance use disorders. I utilize fMRI to investigate cue reactivity in nicotine dependent smokers. I have been involved in multiple clinical trials, ranging from Phase 2 to Phase 4, investigating a variety of pharmacotherapeutic agents for the treatment of substance use disorders and have served as a co-investigator of several laboratory studies exploring the effects of stress on cue-reactivity.
|Clinical and/or Research Expertise|
smoking cessation, neuroimaging of cue-elicited craving, gender differences in substance use disorders, prescription opioid dependence